1-13 of 13
Keywords: therapy
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Biochem Soc Trans (2021) 49 (4): 1803–1816.
Published: 26 August 2021
...Paola Fulghieri; Lucia Anna Stivala; Virginie Sottile Cancer has been traditionally viewed as a disease characterised by excessive and uncontrolled proliferation, leading to the development of cytotoxic therapies against highly proliferating malignant cells. However, tumours frequently relapse due...
Biochem Soc Trans (2014) 42 (6): 1752–1755.
Published: 17 November 2014
... the pharmacokinetics and pharmacodynamics are dissociated. The three murine models to be discussed each show BiP induced long-term therapeutic protection and therefore has potential for long-lasting drug-free therapy in rheumatoid arthritis (RA). BiP is well characterized in the literature as a ubiquitous...
Biochem Soc Trans (2012) 40 (1): 31–36.
Published: 19 January 2012
... that make the ATX–LPA signalling axis an emerging target for cancer therapy. 1 These authors contributed equally to this paper. 2 To whom correspondence should be addressed (email gtigyi@uthsc.edu ). 12 5 2011 Many cancers secrete ATX, which contributes to their invasive...
Biochem Soc Trans (2011) 39 (6): 1612–1618.
Published: 21 November 2011
...Chern Ein Oon; Adrian L. Harris Notch signalling is a key pathway controlling angiogenesis in normal tissues and tumours. This has become a major focus of development of anticancer therapy, but to develop this appropriately, we need further understanding of the mechanisms of regulation of Dll4...
Biochem Soc Trans (2010) 38 (2): 343–347.
Published: 22 March 2010
...Qizhi Huang; Laura J. Hardie Biomarkers are needed to screen multiple stages in the clinical pathway of Barrett's oesophagus patients; from disease diagnosis to risk stratification and predicting response to therapy. Routes to the identification of biomarkers have been recognized by known molecular...
Biochem Soc Trans (2008) 36 (6): 1304–1308.
Published: 19 November 2008
... with the involvement of metal ions. Chelation therapy could provide a valuable therapeutic approach to such disease states, since metals, particularly iron, are realistic pharmacological targets for the rational design of new therapeutic agents. 1 To whom correspondence should be addressed (email robert.hider...
Biochem Soc Trans (2007) 35 (2): 416–420.
Published: 20 March 2007
.... 1 To whom correspondence should be addressed (email dominic.walsh@ucd.ie ). 5 10 2006 © 2007 The Biochemical Society 2007 Alzheimer's disease β-amyloid-cleaving enzyme (BACE) amyloid precursor protein (APP) amyloid precursor-like protein (APLP) γ-secretase therapy...
Biochem Soc Trans (2007) 35 (2): 411–415.
Published: 20 March 2007
.... 2007 37 171 213 gene knockdown neuropsychiatric disorder short interfering RNA (siRNA) small hairpin RNA (shRNA) target validation therapy Disorders of the central nervous system are among the most complex, poorly understood, and debilitating diseases. The burgeoning...
Biochem Soc Trans (2006) 34 (2): 313–316.
Published: 20 March 2006
... will play an even more vital role in the generation of future therapies. 1 To whom correspondence should be addressed (email Graham.Belfield@astrazeneca.com ). 20 1 2006 © 2006 The Biochemical Society 2006 The genetic modification of animal models is becoming an increasingly common...
Biochem Soc Trans (2003) 31 (4): 770–773.
Published: 01 August 2003
... the natural history of (e.g. rheumatoid arthritis, cystic fibrosis), a disease. MBL (plasma-derived or recombinant) therapy has yet to be shown to be safe and effective. Potentially it may be useful in MBL-deficient patients to reduce susceptibility to, or enhance recovery from, bacterial infection...
Biochem Soc Trans (2003) 31 (4): 763–767.
Published: 01 August 2003
... Biochemical Society 2003 complement innate immunity mannan-binding lectin (MBL) recombinant mannan-binding lectin therapy Abbreviations used: MBL, mannan-binding lectin; pMBL, plasma-derived MBL; rMBL, recombinant MBL; MASP, MBL-associated serine protease; MALDI-MS, matrix-assisted laser...
Biochem Soc Trans (2003) 31 (4): 768–769.
Published: 01 August 2003
...H. Valdimarsson Our first experience of mannan-binding lectin (MBL)-replacement therapy was with a patient experiencing recurrent erythema multiforme associated with reactivation of herpes simplex virus; his erythematous eruptions could be controlled with infusions of fresh frozen plasma containing...
Biochem Soc Trans (2002) 30 (6): 1019–1026.
Published: 01 November 2002
... therapy in disease. Here we will review the development of anticomplement therapeutics from the first generation agents, which are unmodified recombinant forms of natural regulators, to recent strategies for making better drugs. We will describe strategies for targeting the anticomplement activity...